Colorado Springs / Colorado / United States
Spectranetics was one of the first companies in the world to explore the possibility of using photo-ablative lasers to clear occluded arteries. After five years of product development, Spectranetics technology was first used in a procedure at the Texas Heart Institute in 1989. Since then, the company has been developing, manufacturing and marketing its ultraviolet excimer laser technology to physicians and hospitals worldwide. This leading-edge technology is used in multiple cardiovascular procedures to remove arterial blockages and scar tissue while holding pacemaker and ICD cardiac leads in place. Spectranetics maintains its headquarters in Colorado Springs, Colo. The companys common stock is traded on NASDAQ.
